Improving Monitoring of Postoperative Crohn’s Disease Recurrence
-
By
-
Margery Weinstein
-
February 2, 2026
-
4 min
By
Margery Weinstein
February 2, 2026
by Margery Weinstein
February 2, 2026
by Jiani Hu, Xianlan Xiang, Yichao Zhou, Peng Cai, Menglei Zhu, Jie Zhu
April 30, 2026
The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production
May 12, 2026